Parallel vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Paris France YC W24 AI medical coding and admin agents for hospitals; $3.5M seed Apr 2025 led by Frst with Paul Meta/McKinsey and Thomas CTO adapting to fragmented hospital software competing with Nuance for healthcare admin automation.
About
Parallel is a Paris, France-based AI healthcare administration platform — backed by Y Combinator (W24) with $3.5 million in seed funding in April 2025 led by Frst with Y Combinator — providing hospitals and healthcare providers with vertical AI agents that automate time-consuming administrative tasks, starting with medical coding, using generative AI that streamlines hospital operations, improves billing accuracy, and reduces the administrative workload on medical staff — allowing clinicians to focus on patient care rather than documentation and coding compliance. Founded in 2024 by Paul Lafforgue (Meta/McKinsey background) and Thomas Sohet (CTO), with Yago as a co-founder, Parallel's 6-person Paris team designs AI agents that adapt to real-world hospital environments and fragmented software stacks.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.